European J Pediatr Surg Rep. 2013; 01(01): 024-026
DOI: 10.1055/s-0033-1341418
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Use of Mitomycin C for Refractory Esophageal Stricture following Tracheoesophageal Fistula Repair

Anna Lakoma
1   Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, United States
,
Sara C. Fallon
1   Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, United States
,
Shawn Mathur
1   Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, United States
,
Eugene S. Kim
1   Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, United States
› Author Affiliations
Further Information

Publication History

04 December 2012

16 January 2013

Publication Date:
19 March 2013 (online)

Abstract

Esophageal stricture is a well-described complication following tracheoesophageal fistula repair. Herein, we report two patients who had persistent esophageal strictures after several months of repeat balloon dilatations. Each patient was treated with a single application of topical mitomycin C in addition to esophageal dilatation, which resulted in complete resolution of the stricture.

 
  • References

  • 1 Engum SA, Grosfeld JL, West KW, Rescorla FJ, Scherer III LR. Analysis of morbidity and mortality in 227 cases of esophageal atresia and/or tracheoesophageal fistula over two decades. Arch Surg 1995; 130 (5) 502-508 , discussion 508–509
  • 2 Berger M, Ure B, Lacher M. Mitomycin C in the therapy of recurrent esophageal strictures: hype or hope?. Eur J Pediatr Surg 2012; 22 (2) 109-116
  • 3 Olutoye OO, Shulman RJ, Cotton RT. Mitomycin C in the management of pediatric caustic esophageal strictures: a case report. J Pediatr Surg 2006; 41 (5) e1-e3
  • 4 Kovesi T, Rubin S. Long-term complications of congenital esophageal atresia and/or tracheoesophageal fistula. Chest 2004; 126 (3) 915-925
  • 5 Uhlen S, Fayoux P, Vachin F , et al. Mitomycin C: an alternative conservative treatment for refractory esophageal stricture in children? . Endoscopy 2006; 38 (4) 404-407
  • 6 Türkyilmaz Z, Sönmez K, Demirtola A , et al. Mitomycin C prevents strictures in caustic esophageal burns in rats. J Surg Res 2005; 123 (2) 182-187
  • 7 Holló G. Wound healing and glaucoma surgery: modulating the scarring process with conventional antimetabolites and new molecules. Dev Ophthalmol 2012; 50: 79-89
  • 8 Shridharani SM, Magarakis M, Manson PN, Singh NK, Basdag B, Rosson GD. The emerging role of antineoplastic agents in the treatment of keloids and hypertrophic scars: a review. Ann Plast Surg 2010; 64 (3) 355-361
  • 9 Rosseneu S, Afzal N, Yerushalmi B , et al. Topical application of mitomycin-C in oesophageal strictures. J Pediatr Gastroenterol Nutr 2007; 44 (3) 336-341
  • 10 Heran MK, Pham TH, Butterworth S, Robinson A. Use of a microporous polytetrafluoroethylene catheter balloon to treat refractory esophageal stricture: a novel technique for delivery of mitomycin C. J Pediatr Surg 2011; 46 (4) 776-779
  • 11 Michaud L, Gottrand F. Anastomotic strictures: conservative treatment. J Pediatr Gastroenterol Nutr 2011; 52 (Suppl. 01) S18-S19
  • 12 Heran MK, Baird R, Blair GK, Skarsgard ED. Topical mitomycin-C for recalcitrant esophageal strictures: a novel endoscopic/fluoroscopic technique for safe endoluminal delivery. J Pediatr Surg 2008; 43 (5) 815-818